-
Mashup Score: 13ARVO 2024: Impact of early intraretinal fluid reduction on one-year outcomes in diabetic macular edema - 2 day(s) ago
At this year’s ARVO meeting, Dolly Chang, MD, PhD, presented data on the early fluid reduction in patients with diabetic macular edema, and how that correlates with 1-year outcome with a deep learning-based retina segmentation tool using the Phase 2 BOLIVAR study.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2Study reveals lower vision specific quality of life in children with cortical/cerebral visual impairment - 2 day(s) ago
Investigators recruited children with CVI and normal controls who were between the ages of 12 months and 12 years. The children with CVI underwent a complete pediatric neuro-ophthalmologic examination.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 15ARVO 2024: Researchers drive innovation in retinal research - 3 day(s) ago
A quartet of studies presented at the Association for Research in Vision and Ophthalmology’s 2024 Annual Meeting addressed diverse retina-related challenges and unveiled findings with the potential to revolutionize vision science.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2Study identifies risk factors associated with Diabetic Retinopathy in youth with Type 1 Diabetes - 3 day(s) ago
The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2Study identifies risk factors associated with Diabetic Retinopathy in youth with Type 1 Diabetes - 3 day(s) ago
The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 9ARVO 2024: Protocol AA from the DRCR Retina Network - 3 day(s) ago
At this year’s ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network and the effect of diabetic retinopathy lesion location and severity on the risk for progression in the long term.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0
Priorities can ensure optimal outcomes for patients diagnosed with diseases.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 10
The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of corneal edema secondary to corneal endothelial dysfunction.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Aurion Biotech announced dosing of all subjects in its Phase 1/2 CLARA trial of AURN001, a combination cell therapy product comprised of neltependocel and Y-27632 for the treatment of corneal edema secondary to corneal endothelial dysfunction Read More: https://t.co/SdaL2tYduL https://t.co/UtBqyrMuT7
-
-
Mashup Score: 0Inflammasome Therapeutics doses first patient in Phase 1 trial of Kamuvudine-8 for geographic atrophy - 5 day(s) ago
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Companies prepare to unveil research at ARVO 2024 conference - 5 day(s) ago
More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
At ARVO, Dolly Chang, MD, PhD, presented data on the early fluid reduction in patients with diabetic macular edema, and how that correlates with 1-year outcome with a deep learning-based retina segmentation tool using the Phase 2 BOLIVAR study. Watch: https://t.co/xffCspBhS2 https://t.co/4McAROQXEF